Paul Knight

Stock Analyst at KeyBanc

(3.21)

# 2,481

Out of 4,516 analysts

261

Total ratings

43.8%

Success rate

3.2%

Average return

Main Sectors:

Healthcare Industrials Technology

Top Industries:

Diagnostics & Research Medical Instruments & Supplies Medical Devices Biotechnology Drug Manufacturers - Specialty & Generic

Stocks Rated by Paul Knight

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	WST West Pharmaceutical Services	Maintained: Buy	$350 → $390	$357.65	+9.05%	16	Jul 2, 2026
	CSTL Castle Biosciences	Maintained: Buy	$50 → $35	$23.12	+51.38%	9	May 29, 2026
	RPID Rapid Micro Biosystems	Maintained: Buy	$8 → $5	$2.07	+141.55%	3	May 29, 2026
	CYRX Cryoport	Maintained: Buy	$15 → $17	$16.07	+5.79%	10	May 20, 2026
	TECH Bio-Techne	Maintained: Hold	n/a	$71.23	-	19	May 7, 2026
	XGN Exagen	Maintained: Buy	$15 → $10	$4.09	+144.50%	11	Mar 11, 2026
	STVN Stevanato Group	Rated: Buy	$37 → $32	$19.82	+61.45%	7	Mar 5, 2026
	TKNO Alpha Teknova	Maintained: Hold	n/a	$5.41	-	4	Feb 27, 2026
	LAB Standard BioTools	Maintained: Hold	n/a	$0.8379	-	9	Feb 25, 2026
	RGEN Repligen	Maintained: Buy	$220	$147.13	+49.53%	13	Feb 25, 2026
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Hold	n/a	$4.61	-	3	Dec 29, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Rated: Buy	$310	$199.05	+55.74%	9	Dec 18, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Upgraded: Buy	$750	$534.07	+40.43%	9	Dec 8, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	€415.00 → €320.00	€250.00	+28.00%	2	Oct 7, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	$33	$28.65	+15.18%	10	Oct 3, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	$125	$111.21	+12.40%	12	Sep 16, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	$220	$128.28	+71.50%	2	Sep 10, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiated Coverage: Buy	CHF 525.00	CHF 368.00	+42.66%	1	Sep 4, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Reiterated: Hold	n/a	$135.20	-	12	Aug 28, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	$460	$376.39	+22.21%	9	Aug 18, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Reiterated: Buy	$40 → $30	$11.29	n/a	3	Jun 3, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	$7 → $30	$5.93	n/a	9	Apr 9, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	n/a	$29.14	n/a	2	Mar 31, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Reiterated: Hold	n/a	$94.64	n/a	3	Feb 5, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	CHF 610.00 → CHF 635.00	CHF 582.40	n/a	6	Jan 30, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Rated: Hold	n/a	$6.51	n/a	9	May 9, 2024
	XXXX XXXXXXXXXXXXXXXX Upgrade	Rated: Hold	n/a	$25.44	n/a	9	Nov 14, 2023
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	$300	$231.21	n/a	1	May 5, 2022
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	$250	$207.83	n/a	1	Apr 28, 2022
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	n/a	$4.46	n/a	6	Mar 14, 2022
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiated Coverage: Buy	n/a	$1.50	n/a	1	Apr 15, 2020
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Hold	$20 → $30	$14.23	n/a	3	Feb 27, 2020
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	$6 → $2	$0.0006	n/a	8	Nov 26, 2019
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	n/a	$5.66	n/a	2	Jul 24, 2019
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	n/a	$56.62	n/a	7	Nov 29, 2018
	XXXX XXXXXXXXXXXXXXXX Upgrade	Upgraded: Hold	n/a	$191.20	n/a	6	Oct 23, 2017
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	n/a	$59.83	n/a	4	Mar 27, 2017
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	n/a	$1.31	n/a	2	Mar 11, 2016
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiated Coverage: Buy	n/a	$28.93	n/a	1	Feb 10, 2016
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	$75 → $85	$222.74	n/a	2	Jul 24, 2014
	XXXX XXXXXXXXXXXXXXXX Upgrade	Upgraded: Buy	n/a	$2.27	n/a	1	May 5, 2014
	XXXX XXXXXXXXXXXXXXXX Upgrade	Rated: Hold	$61 → $46	$9.67	n/a	2	Dec 19, 2013
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiated Coverage: Hold	$255	$1,314.83	n/a	1	Aug 15, 2013
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiated Coverage: Hold	$24	$41.56	n/a	1	Aug 15, 2013
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiated Coverage: Hold	$18	$0.3951	n/a	1	Aug 15, 2013

West Pharmaceutical Services

Jul 2, 2026

Maintained: Buy

Price Target: $350 → $390

Current: $357.65

Upside: +9.05%

Castle Biosciences

May 29, 2026

Maintained: Buy

Price Target: $50 → $35

Current: $23.12

Upside: +51.38%

Rapid Micro Biosystems

May 29, 2026

Maintained: Buy

Price Target: $8 → $5

Current: $2.07

Upside: +141.55%

Cryoport

May 20, 2026

Maintained: Buy

Price Target: $15 → $17

Current: $16.07

Upside: +5.79%

Bio-Techne

May 7, 2026

Maintained: Hold

Price Target: n/a

Current: $71.23

Upside: -

Exagen

Mar 11, 2026

Maintained: Buy

Price Target: $15 → $10

Current: $4.09

Upside: +144.50%

Stevanato Group

Mar 5, 2026

Rated: Buy

Price Target: $37 → $32

Current: $19.82

Upside: +61.45%

Alpha Teknova

Feb 27, 2026

Maintained: Hold

Price Target: n/a

Current: $5.41

Upside: -

Standard BioTools

Feb 25, 2026

Maintained: Hold

Price Target: n/a

Current: $0.8379

Upside: -

Repligen

Feb 25, 2026

Maintained: Buy

Price Target: $220

Current: $147.13

Upside: +49.53%

Dec 29, 2025

Maintained: Hold

Price Target: n/a

Current: $4.61

Upside: -

Dec 18, 2025

Rated: Buy

Price Target: $310

Current: $199.05

Upside: +55.74%

Dec 8, 2025

Upgraded: Buy

Price Target: $750

Current: $534.07

Upside: +40.43%

Oct 7, 2025

Maintained: Buy

Price Target: €415.00 → €320.00

Current: €250.00

Upside: +28.00%

Oct 3, 2025

Maintained: Buy

Price Target: $33

Current: $28.65

Upside: +15.18%

Sep 16, 2025

Maintained: Buy

Price Target: $125

Current: $111.21

Upside: +12.40%

Sep 10, 2025

Maintained: Buy

Price Target: $220

Current: $128.28

Upside: +71.50%

Sep 4, 2025

Initiated Coverage: Buy

Price Target: CHF 525.00

Current: CHF 368.00

Upside: +42.66%

Aug 28, 2025

Reiterated: Hold

Price Target: n/a

Current: $135.20

Upside: -

Aug 18, 2025

Maintained: Buy

Price Target: $460

Current: $376.39

Upside: +22.21%

Jun 3, 2025

Reiterated: Buy

Price Target: $40 → $30

Current: $11.29

Upside: n/a

Apr 9, 2025

Downgraded: Hold

Price Target: $7 → $30

Current: $5.93

Upside: n/a

Mar 31, 2025

Downgraded: Hold

Price Target: n/a

Current: $29.14

Upside: n/a

Feb 5, 2025

Reiterated: Hold

Price Target: n/a

Current: $94.64

Upside: n/a

Jan 30, 2025

Maintained: Buy

Price Target: CHF 610.00 → CHF 635.00

Current: CHF 582.40

Upside: n/a

May 9, 2024

Rated: Hold

Price Target: n/a

Current: $6.51

Upside: n/a

Nov 14, 2023

Rated: Hold

Price Target: n/a

Current: $25.44

Upside: n/a

May 5, 2022

Maintained: Buy

Price Target: $300

Current: $231.21

Upside: n/a

Apr 28, 2022

Maintained: Buy

Price Target: $250

Current: $207.83

Upside: n/a

Mar 14, 2022

Downgraded: Hold

Price Target: n/a

Current: $4.46

Upside: n/a

Apr 15, 2020

Initiated Coverage: Buy

Price Target: n/a

Current: $1.50

Upside: n/a

Feb 27, 2020

Maintained: Hold

Price Target: $20 → $30

Current: $14.23

Upside: n/a

Nov 26, 2019

Downgraded: Hold

Price Target: $6 → $2

Current: $0.0006

Upside: n/a

Jul 24, 2019

Downgraded: Hold

Price Target: n/a

Current: $5.66

Upside: n/a

Nov 29, 2018

Downgraded: Hold

Price Target: n/a

Current: $56.62

Upside: n/a

Oct 23, 2017

Upgraded: Hold

Price Target: n/a

Current: $191.20

Upside: n/a

Mar 27, 2017

Downgraded: Hold

Price Target: n/a

Current: $59.83

Upside: n/a

Mar 11, 2016

Downgraded: Hold

Price Target: n/a

Current: $1.31

Upside: n/a

Feb 10, 2016

Initiated Coverage: Buy

Price Target: n/a

Current: $28.93

Upside: n/a

Jul 24, 2014

Downgraded: Hold

Price Target: $75 → $85

Current: $222.74

Upside: n/a

May 5, 2014

Upgraded: Buy

Price Target: n/a

Current: $2.27

Upside: n/a

Dec 19, 2013

Rated: Hold

Price Target: $61 → $46

Current: $9.67

Upside: n/a

Aug 15, 2013

Initiated Coverage: Hold

Price Target: $255

Current: $1,314.83

Upside: n/a

Aug 15, 2013

Initiated Coverage: Hold

Price Target: $24

Current: $41.56

Upside: n/a

Aug 15, 2013

Initiated Coverage: Hold

Price Target: $18

Current: $0.3951

Upside: n/a